Display options
Share it on

Acta Histochem Cytochem. 2010 Feb 27;43(1):1-7. doi: 10.1267/ahc.09036. Epub 2010 Feb 04.

The air liquid-interface, a skin microenvironment, promotes growth of melanoma cells, but not their apoptosis and invasion, through activation of mitogen-activated protein kinase.

Acta histochemica et cytochemica

Chong Hong Yee, Shigehisa Aoki, Kazuyoshi Uchihashi, Aki Matsunobu, Fumio Yamasaki, Noriyuki Misago, Meihua Piao, Uemura Tetsuji, Nobuhisa Yonemitsu, Hajime Sugihara, Shuji Toda

Affiliations

  1. Department of Pathology & Microbiology, Faculty of Medicine, Saga University, Japan.

PMID: 20300218 PMCID: PMC2840220 DOI: 10.1267/ahc.09036

Abstract

The air-liquid interface (ALI) is a common microenvironment of the skin, but it is unknown whether the ALI affects melanoma cell behaviors. Using a collagen gel invasion assay, immunohistochemistry, and Western blots, here we show that melanoma cell proliferation in cultures with an ALI is higher than melanoma cell proliferation in submerged cultures. Bromodeoxyuridine (BrdU) uptake, an indicator of cell proliferation, of melanoma cells at the ALI was about 3 times that of submerged cells, while ALI and submerged melanoma cells had similar levels of single-stranded DNA (a marker of apoptosis). The ALI enhanced the expression of Raf-1, MEK-1 and pERK-1/2 components of the mitogen-activated protein kinase (MAPK) cascade, in cells more than the submerged condition did. The increases in BrdU uptake and pERK-1/2 expression promoted by ALI was abolished by the MEK inhibitor, PD-98059. ALI-treated and submerged melanoma cells did not infiltrate into the collagen gel, and they showed no significant difference in the expression of the invasion- and motility-related molecules, matrix metalloproteinase-1 and -9, laminin 5, and filamin A. Our data indicate that the ALI, a skin microenvironment, accelerates the growth, but not the apoptosis or invasion, of melanoma cells through MAPK activation.

Keywords: air-liquid interface; collagen gel invasion assay; melanoma; mitogen-activated protein kinase; proliferation

References

  1. Cancer Sci. 2008 Dec;99(12):2417-27 - PubMed
  2. Int Rev Cytol. 1993;146:191-260 - PubMed
  3. Am J Surg Pathol. 2006 Nov;30(11):1396-400 - PubMed
  4. Nature. 1965 Apr 10;206(980):199 - PubMed
  5. Clin Dermatol. 2009 Nov-Dec;27(6):564-87 - PubMed
  6. Cancer Res. 1978 Nov;38(11 Pt 1):3879-85 - PubMed
  7. Biochem Biophys Res Commun. 2005 Jan 28;326(4):866-72 - PubMed
  8. Oncogene. 2004 Nov 18;23(54):8796-804 - PubMed
  9. Endocrinology. 2004 Feb;145(2):613-9 - PubMed
  10. FASEB J. 1999 May;13(8):781-92 - PubMed
  11. Am J Physiol Cell Physiol. 2001 Jan;280(1):C135-45 - PubMed
  12. In Vitro Cell Dev Biol. 1991 Feb;27A(2):142-6 - PubMed
  13. Int J Med Microbiol. 2002 Feb;291(6-7):433-7 - PubMed
  14. J Invest Dermatol. 2001 Aug;117(2):244-50 - PubMed
  15. Tohoku J Exp Med. 1998 Jun;185(2):89-100 - PubMed
  16. Pigment Cell Melanoma Res. 2009 Dec;22(6):799-808 - PubMed
  17. Hum Pathol. 1994 Jul;25(7):709-14 - PubMed
  18. N Engl J Med. 2006 Jul 6;355(1):51-65 - PubMed
  19. Acta Histochem Cytochem. 2009 Apr 28;42(2):39-45 - PubMed
  20. J Invest Dermatol. 2010 Jan;130(1):28-37 - PubMed
  21. APMIS. 2007 Oct;115(10):1161-76 - PubMed
  22. Curr Pharm Des. 2004;10(16):1907-14 - PubMed
  23. Acta Histochem Cytochem. 2006 Dec 28;39(6):163-72 - PubMed
  24. Nature. 1974 Sep 27;251(5473):317-9 - PubMed

Publication Types